Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Toxic effect type:
dose-dependent

Effects on fertility

Description of key information

Penicillins and related β-lactam antibiotics have a low toxicity profile for both the pregnant and non-pregnant patient when used in therapeutic doses. Only penicillin allergy may present a problem. Penicillins cross the placenta in low concentrations, and can be detected in amniotic fluid.


There is no evidence that penicillins have teratogenic or embryo/fetotoxic properties. There are no differences between the various penicillins regarding their safety in pregnancy.
Penicillins can be safely used during pregnancy in the usual doses; they are the antibiotics of choice in pregnancy (Drugs during Pregnancy and Lactation, 2007)


Penicillins and their newer derivatives are the most widely prescribed antimicrobial class during pregnancy: FDA assigned them to pregnancy category B. Potential Adverse Effects on Fetus: None known. Fetal serum levels 20%-50% of maternal. Potential Side Effects on Breast-fed Infant: Significant problems not documented, but may lead to sensitization, diarrhoea, candidiasis, or skin rash in infant. Animal studies failed to reveal evidence of fetal harm. Adverse effects have not been reported during human use. Penicillin is only recommended for use during pregnancy when benefit outweighs risk: the group of penicillins are regarded as being devoid of reprotoxic potential.

Effect on fertility: via oral route
Endpoint conclusion:
no adverse effect observed
Effect on fertility: via inhalation route
Endpoint conclusion:
no adverse effect observed

Effects on developmental toxicity

Description of key information

Penicillins belong to the β-lactam antibiotics. They inhibit cell-wall synthesis in bacteria and have bactericidal properties. Similar metabolic pathways do not exist in mammals, and therefore penicillins and related β-lactam antibiotics have a low toxicity profile for both the pregnant and non-pregnant patient when used in therapeutic doses. Only penicillin allergy may present a problem. 

Penicillins cross the placenta in low concentrations, and can be detected in amniotic fluid. Elimination of penicillins is more rapid in pregnant women, and therefore dosage or dosage intervals should be adjusted if necessary (Heikkilä 1994, Chamberlain 1993). There is no evidence that penicillins have teratogenic or embryo/fetotoxic properties (Berkovitch 2004, Jepsen 2003, Dencker 2002, Larsen 2001, 2000, Czeizel 2000A, 1998). Penicillins have been selected as the antibiotics of choice in pregnancy (Drugs during Pregnancy and Lactation, 2007).

Justification for classification or non-classification

Based upon extensive human experience, classificaiton for reproductive toxicity is not justified.

Additional information